JPRN-jRCTs031180133已完成2 期
PCAB-based H.pylori eradication study for patients with penicillin allergy
Sue Soichiro0 个研究点目标入组 60 人开始时间: 2019年2月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
First line 7-days therapy with vonoprazan, clarithromycin and metronidazole, and second line 7-days therapy with vonoprazan, metronidazole and sitafloxacin showed sufficient efficacy and safety for Helicobacter pylori infected patients with penicillin allergy.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Penicillin allergic patients with H.pylori infection who want to take eradication treatment. Patients who give a written informed consent.
排除标准
- •Past history of taking second line H.pylori eradication therapy. Pregnancy or lactation. Past history of allergy for the drugs used in this therapy. Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. Patients who are disqualified for the study by physicians.
研究者
相似试验
已完成
不适用
PCAB-based H.pylori eradication study for patients with penicillin allergyHelicobacter pylori infectionJPRN-UMIN000016335Yokohama City University Hospital60
已完成
4 期
Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential TherapyHelicobacter PyloriNCT05371249Fu Jen Catholic University Hospital628
招募中
4 期
Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradicationthe Eradication Rates of Helicobacter PyloriNCT06168214Xijing Hospital of Digestive Diseases1,404
已完成
不适用
Randomized Controlled Trial for H.pylori first line eradication therapy considering clarithromycin resistance: PCAB vs PPIHelicobacter pylori infectionJPRN-UMIN000016337Yokohama City University Hospital147
招募中
4 期
Helicobacter Pylori Eradication and Follow-upHelicobacter Pylori InfectionNCT05061732Shanghai Zhongshan Hospital4,447